{"date":"2025-12-12","count":21,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1813-2025-12-12-2131-163mvu1","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"21:31:39","subject":"依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告","clause":"第23款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-12-12 21:31，「依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-12-12-1816-itj29f","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"18:16:50","subject":"本公司修訂「國內第七次無擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿公告","clause":"第53款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-12-12 18:16，「本公司修訂「國內第七次無擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2025-12-12-1816-10e2k5","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"18:16:35","subject":"本公司修訂「國內第六次有擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿公告","clause":"第53款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2025-12-12 18:16，「本公司修訂「國內第六次有擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-12-12-1756-1aomjka","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"17:56:34","subject":"公告本公司買回庫藏股期間屆滿及執行情形","clause":"第35款","fact_date":"2025-12-13","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-12-12 17:56，「公告本公司買回庫藏股期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-12-12-1720-hue3pa","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-12","time":"17:20:30","subject":"公告本公司董事會決議109年度普通股現金增資計畫變更案","clause":"第14款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-12-12 17:20，「公告本公司董事會決議109年度普通股現金增資計畫變更案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-12-12-1700-n8xr9k","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-12-12","time":"17:00:20","subject":"(補充說明)本公司TAH3311抗血栓口溶膜505(b)(2)新劑型新藥藥證申請接獲美國食品藥物管理局(FDA)查驗文件退件(Refusal To File,以下簡稱RTF)","clause":"第44款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-12-12 17:00，「(補充說明)本公司TAH3311抗血栓口溶膜505(b)(2)新劑型新藥藥證申請接獲美國食品藥物管理局(FDA)查驗文件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-12-12-1700-scpg66","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-12-12","time":"17:00:01","subject":"公告本公司董事會擬決議解除經理人競業禁止限制","clause":"第22款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-12-12 17:00，「公告本公司董事會擬決議解除經理人競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-12-12-1622-z6rxem","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"16:22:23","subject":"公告本公司股票初次上櫃前現金增資發行新股承銷價格","clause":"第44款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-12-12 16:22，「公告本公司股票初次上櫃前現金增資發行新股承銷價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2025-12-12-1621-16xx3hr","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"16:21:56","subject":"代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品","clause":"第20款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2025-12-12 16:21，「代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-12-12-1621-dw6j3n","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"16:21:54","subject":"代子公司Chemix Inc.公告更換會計師事務所","clause":"第7款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-12-12 16:21，「代子公司Chemix Inc.公告更換會計師事務所」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-12-12-1621-a2tcmo","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"16:21:08","subject":"代子公司Chemix Inc.公告董事會決議召開2026年股東大會","clause":"第17款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-12-12 16:21，「代子公司Chemix Inc.公告董事會決議召開2026年股東大會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-12-12-1606-ub84r7","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-12","time":"16:06:27","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-12-12 16:06，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-12-12-1603-1d05iuh","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"16:03:09","subject":"公告本公司受邀參加凱基證券所舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-16","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-12-12 16:03，「公告本公司受邀參加凱基證券所舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-12-12-1559-jhodrp","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"15:59:05","subject":"代重要子公司益興生醫股份有限公司公告董事會通過會計主管任命案","clause":"第8款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-12-12 15:59，「代重要子公司益興生醫股份有限公司公告董事會通過會計主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-12-12-1511-1u6pvow","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"15:11:06","subject":"公告本公司取得經濟部產業發展署出具「係屬科技事業且具市場性」之意見書","clause":"第44款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-12-12 15:11，「公告本公司取得經濟部產業發展署出具「係屬科技事業且具市場性」之意見書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-12-12-1508-14ayuye","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-12","time":"15:08:51","subject":"本公司眼藥水SHJ002-DED治療乾眼症，已獲美國FDA許可進行三期臨床試驗","clause":"第8款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-12-12 15:08，「本公司眼藥水SHJ002-DED治療乾眼症，已獲美國FDA許可進行三期臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-12-12-1439-xdghze","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"14:39:42","subject":"代子公司太景生物科技(股)公司及太景醫藥研發(北京)公告與INSILICO MEDICINE LTD.及INSILICO MEDICINE IP LIMITED簽署授權協議，取得慢性腎臟病(CKD)貧血新藥ISM4808權利。","clause":"第10款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-12-12 14:39，「代子公司太景生物科技(股)公司及太景醫藥研發(北京)公告與INSILICO MEDICINE LTD.及INSILICO」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-12-12-1359-1ynhj41","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-12-12","time":"13:59:19","subject":"公告本公司召開法說會時間及地點","clause":"第12款","fact_date":"2025-12-19","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-12-12 13:59，「公告本公司召開法說會時間及地點」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-12-12-1350-cehf3j","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"13:50:55","subject":"本公司董事會決議通過與子公司泰奇生技股份有限公司進行簡易合併","clause":"第11款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-12-12 13:50，「本公司董事會決議通過與子公司泰奇生技股份有限公司進行簡易合併」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2025-12-12-1341-17elzrv","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"13:41:31","subject":"公告本公司董事會通過財會處處長追認案","clause":"第8款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2025-12-12 13:41，「公告本公司董事會通過財會處處長追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-12-12-0626-18nwjnj","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-12-12","time":"06:26:53","subject":"美國食品藥物管理局(FDA)對本公司專屬授權夥伴Sandoz生物相似藥EG12014凍晶注射劑150毫克藥證申請，提出完全回覆信函","clause":"第51款","fact_date":"2025-12-12","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-12-12 06:26，「美國食品藥物管理局(FDA)對本公司專屬授權夥伴Sandoz生物相似藥EG12014凍晶注射劑150毫克藥證申請，提出完」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}